Market
Scope
The
Live Cell Imaging Market Size was valued at USD 4.7 billion in 2022
and is projected to grow from USD 5.123 Billion in 2023 to USD 8.59 billion by
2030, exhibiting a compound annual growth rate (CAGR) of 9.0% during the
forecast period (2023 - 2030).
The
live cell imaging market refers to the market for technologies and equipment
used for studying live cells in real-time. Live cell imaging is an important
tool in cellular and molecular biology, allowing researchers to observe
cellular processes and interactions in living cells.
The
market for live cell imaging includes a variety of products, such as
microscopes, imaging software, and cell culture and imaging systems. The market
is driven by increasing research activities in the fields of drug discovery, cell biology, and genetics, as well as by
the growing demand for advanced imaging technologies in the healthcare
industry.
Drivers
and Constraints
The
extensive application of live cell imaging technology in novel drug research
and development is expected to underpin the market rise in the near future.
Electronic microscopes and other type of high content screening systems are
deployed in studying colossal medical attributes that impact innovations in
life science. In addition, the availability of modern medical technologies for
enhancing the existing live cell imaging techniques can underpin the expansion
of the live cell imaging market through the study period. Under the present
circumstance, the live cell imaging is used extensively to aid a cure for COVID 19, which can add momentum to the rise of the
live cell imaging market growth. Increase in funding for government cell-based
research can also cause escalation of the market revenue through the study
period. Other causes that can bolster the rise of the live cell imaging market
are changing dynamics of the bioscience field, developing economic conditions,
and easy access to high quality research equipment and services. At the same
time, easy approvals for research from regulatory bodies and rapid spreading of
awareness can also foster the live cell imaging market growth. On the flip
side, lack of expertise and high prohibitive costs are some primary constraints
on the live cell imaging market. However, rise in the utility of live cell
imaging solutions across biotech and pharmaceutical domain can counter the
market slow-down in the coming years.
Market
Segments
The
segment assessment of the live cell imaging market are done by products,
Consumables, Equipment, and Software.
The
technology-based segment of the live cell imaging market are Fluorescence
Recovery After Photobleaching, Fluorescence Resonance Energy Transfer,
Ratiometric Imaging, High-Content Analysis, Total Internal Reflection
Fluorescence Microscopy, Fluorescence in Situ Hybridization, and Multiphoton
Excitation Microscopy among other technologies.
The
application-based segment of the live cell imaging market are Stem Cells, Cell
Biology, Drug Discovery, and Developmental Biology among others.
The
End-user based segment of the live cell microscopy market are Biotechnology
Companies, Pharmaceutical Companies, Diagnostic Laboratories, and Hospitals
among others.
Regional
Analysis
In
North America, the live cell imaging market can earn decent revenue as
substantial investments are made in R&D activities for pharmaceutical and
biotech sectors. Other factors, such as;
presence of firm healthcare system and need to treat the increase in cases of
difficult-to-treat ailments can support the rise of the market across the
review period.
In
APAC, capitalization on the easy availability of advanced imaging systems and
increase in research to provide better imaging quality and allow efficient
functionality of data can foster the rise of live cell imaging market in the
years to come.
In
EU, the powerful economic conditions of the region allowing the flow of funding
required for R&D can promote the expansion of the market in the upcoming
years. The regions is a house to several renowned live cell imaging solution
provider, which can significantly impact the rise of the regional market in the
approaching years.
Key
Players
The
live cell imaging market players are Nikon Corporation (Japan), BioTek
Instruments (U.S.), Carl Zeiss AG (Germany), Leica Microsystems (Germany),
Sigma-Aldrich Corporation (U.S.), GE Healthcare (U.K.), Olympus Corporation
(Japan), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Molecular
Devices, LCC (U.S.), Becton, Dickinson and Company (U.S.), and Thermo Fisher
Scientific, Inc. (U.S.)
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New
York 10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment